Approval · Notice of Compliance 38374 · 2026
ZOLYMBUS: Notice of Compliance 38374
Issued September 25, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38374
- Date
- September 25, 2026
- Company
- Laboratoires ThéaClermont-Ferrand, Cedex 2, France
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLYMBUS | 02571854 | Approved |
Medicinal ingredients
- BIMATOPROST 0.1 MG per G